A histopathology company that provides specimen processing and pathology consultation, develops assays and is building a histology database for collaboration and crowdsourcing in the biomedical research community.
Founder and CEO, Ke Cheng has expertise in cancer research and mouse histopathology. She received her PhD from Harvard Medical School in the laboratory of Pier Paolo Pandolfi, was a Teaching Fellow at Harvard University, a postdoctoral fellow in the laboratory of Douglas Hanahan at ISREC and a scientist at the cancer diagnostic company Cancer Genetics (CGIX).